Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001062993-23-020921

Director acquired 257,739 shares (grant or award)

  • Director acquired 3,303,699 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kalayoglu Murat Director 2023-11-13 Grant or award +257,739 257,739 D: show line 1 in the form
Kalayoglu Murat Director 2023-11-13 Other acquisition +3,303,699 3,303,699 I: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kalayoglu Murat Director 2023-11-13 Grant or award · Series A Non-Voting Convertible Preferred Stock +14,755.61 14,755.61 D: show line 3 in the form
Kalayoglu Murat Director 2023-11-13 Other acquisition · Series A Non-Voting Convertible Preferred Stock +189,136.77 189,136.77 I: show line 4 in the form
Kalayoglu Murat Director 2023-11-13 Purchase · Series A Non-Voting Convertible Preferred Stock +619.63 $249,999.98 $154,906,738 619.63 I: show line 5 in the form
Loading xslF345X05/form4.xml…